321 related articles for article (PubMed ID: 30869654)
1. Chimeric antigen receptor costimulation domains modulate human regulatory T cell function.
Boroughs AC; Larson RC; Choi BD; Bouffard AA; Riley LS; Schiferle E; Kulkarni AS; Cetrulo CL; Ting D; Blazar BR; Demehri S; Maus MV
JCI Insight; 2019 Mar; 5(8):. PubMed ID: 30869654
[TBL] [Abstract][Full Text] [Related]
2. Chimeric Antigen Receptor (CAR) Treg: A Promising Approach to Inducing Immunological Tolerance.
Zhang Q; Lu W; Liang CL; Chen Y; Liu H; Qiu F; Dai Z
Front Immunol; 2018; 9():2359. PubMed ID: 30369931
[TBL] [Abstract][Full Text] [Related]
3. Precision Engineering of an Anti-HLA-A2 Chimeric Antigen Receptor in Regulatory T Cells for Transplant Immune Tolerance.
Muller YD; Ferreira LMR; Ronin E; Ho P; Nguyen V; Faleo G; Zhou Y; Lee K; Leung KK; Skartsis N; Kaul AM; Mulder A; Claas FHJ; Wells JA; Bluestone JA; Tang Q
Front Immunol; 2021; 12():686439. PubMed ID: 34616392
[TBL] [Abstract][Full Text] [Related]
4. Tregs integrate native and CAR-mediated costimulatory signals for control of allograft rejection.
Rosado-Sánchez I; Haque M; Salim K; Speck M; Fung VC; Boardman DA; Mojibian M; Raimondi G; Levings MK
JCI Insight; 2023 Oct; 8(19):. PubMed ID: 37669115
[TBL] [Abstract][Full Text] [Related]
5. Human CD8+ Tregs expressing a MHC-specific CAR display enhanced suppression of human skin rejection and GVHD in NSG mice.
Bézie S; Charreau B; Vimond N; Lasselin J; Gérard N; Nerrière-Daguin V; Bellier-Waast F; Duteille F; Anegon I; Guillonneau C
Blood Adv; 2019 Nov; 3(22):3522-3538. PubMed ID: 31730699
[TBL] [Abstract][Full Text] [Related]
6. CD4
Fu RY; Chen AC; Lyle MJ; Chen CY; Liu CL; Miao CH
Cell Immunol; 2020 Dec; 358():104216. PubMed ID: 32987195
[TBL] [Abstract][Full Text] [Related]
7. Regulating the regulators: Is introduction of an antigen-specific approach in regulatory T cells the next step to treat autoimmunity?
Janssens I; Cools N
Cell Immunol; 2020 Dec; 358():104236. PubMed ID: 33137651
[TBL] [Abstract][Full Text] [Related]
8. Regulatory T cells engineered with a novel insulin-specific chimeric antigen receptor as a candidate immunotherapy for type 1 diabetes.
Tenspolde M; Zimmermann K; Weber LC; Hapke M; Lieber M; Dywicki J; Frenzel A; Hust M; Galla M; Buitrago-Molina LE; Manns MP; Jaeckel E; Hardtke-Wolenski M
J Autoimmun; 2019 Sep; 103():102289. PubMed ID: 31176558
[TBL] [Abstract][Full Text] [Related]
9. Systematic testing and specificity mapping of alloantigen-specific chimeric antigen receptors in regulatory T cells.
Dawson NA; Lamarche C; Hoeppli RE; Bergqvist P; Fung VC; McIver E; Huang Q; Gillies J; Speck M; Orban PC; Bush JW; Mojibian M; Levings MK
JCI Insight; 2019 Mar; 4(6):. PubMed ID: 30753169
[TBL] [Abstract][Full Text] [Related]
10. Supraphysiological FOXP3 expression in human CAR-Tregs results in improved stability, efficacy, and safety of CAR-Treg products for clinical application.
Henschel P; Landwehr-Kenzel S; Engels N; Schienke A; Kremer J; Riet T; Redel N; Iordanidis K; Saetzler V; John K; Heider M; Hardtke-Wolenski M; Wedemeyer H; Jaeckel E; Noyan F
J Autoimmun; 2023 Jul; 138():103057. PubMed ID: 37224732
[TBL] [Abstract][Full Text] [Related]
11. CD19-targeted CAR regulatory T cells suppress B cell pathology without GvHD.
Imura Y; Ando M; Kondo T; Ito M; Yoshimura A
JCI Insight; 2020 Jul; 5(14):. PubMed ID: 32525846
[TBL] [Abstract][Full Text] [Related]
12. Expression of a Chimeric Antigen Receptor Specific for Donor HLA Class I Enhances the Potency of Human Regulatory T Cells in Preventing Human Skin Transplant Rejection.
Boardman DA; Philippeos C; Fruhwirth GO; Ibrahim MA; Hannen RF; Cooper D; Marelli-Berg FM; Watt FM; Lechler RI; Maher J; Smyth LA; Lombardi G
Am J Transplant; 2017 Apr; 17(4):931-943. PubMed ID: 28027623
[TBL] [Abstract][Full Text] [Related]
13. Engineered regulatory T cells expressing myelin-specific chimeric antigen receptors suppress EAE progression.
De Paula Pohl A; Schmidt A; Zhang AH; Maldonado T; Königs C; Scott DW
Cell Immunol; 2020 Dec; 358():104222. PubMed ID: 33053469
[TBL] [Abstract][Full Text] [Related]
14. Transient mTOR inhibition rescues 4-1BB CAR-Tregs from tonic signal-induced dysfunction.
Lamarthée B; Marchal A; Charbonnier S; Blein T; Leon J; Martin E; Rabaux L; Vogt K; Titeux M; Delville M; Vinçon H; Six E; Pallet N; Michonneau D; Anglicheau D; Legendre C; Taupin JL; Nemazanyy I; Sawitzki B; Latour S; Cavazzana M; André I; Zuber J
Nat Commun; 2021 Nov; 12(1):6446. PubMed ID: 34750385
[TBL] [Abstract][Full Text] [Related]
15. Preventing Lck Activation in CAR T Cells Confers Treg Resistance but Requires 4-1BB Signaling for Them to Persist and Treat Solid Tumors in Nonlymphodepleted Hosts.
Suryadevara CM; Desai R; Farber SH; Choi BD; Swartz AM; Shen SH; Gedeon PC; Snyder DJ; Herndon JE; Healy P; Reap EA; Archer GE; Fecci PE; Sampson JH; Sanchez-Perez L
Clin Cancer Res; 2019 Jan; 25(1):358-368. PubMed ID: 30425092
[TBL] [Abstract][Full Text] [Related]
16. Functional effects of chimeric antigen receptor co-receptor signaling domains in human regulatory T cells.
Dawson NAJ; Rosado-Sánchez I; Novakovsky GE; Fung VCW; Huang Q; McIver E; Sun G; Gillies J; Speck M; Orban PC; Mojibian M; Levings MK
Sci Transl Med; 2020 Aug; 12(557):. PubMed ID: 32817364
[TBL] [Abstract][Full Text] [Related]
17. CD28 costimulation is essential for human T regulatory expansion and function.
Golovina TN; Mikheeva T; Suhoski MM; Aqui NA; Tai VC; Shan X; Liu R; Balcarcel RR; Fisher N; Levine BL; Carroll RG; Warner N; Blazar BR; June CH; Riley JL
J Immunol; 2008 Aug; 181(4):2855-68. PubMed ID: 18684977
[TBL] [Abstract][Full Text] [Related]
18. Combined CD28 and 4-1BB Costimulation Potentiates Affinity-tuned Chimeric Antigen Receptor-engineered T Cells.
Drent E; Poels R; Ruiter R; van de Donk NWCJ; Zweegman S; Yuan H; de Bruijn J; Sadelain M; Lokhorst HM; Groen RWJ; Mutis T; Themeli M
Clin Cancer Res; 2019 Jul; 25(13):4014-4025. PubMed ID: 30979735
[TBL] [Abstract][Full Text] [Related]
19. Building a CAR-Treg: Going from the basic to the luxury model.
Rosado-Sánchez I; Levings MK
Cell Immunol; 2020 Dec; 358():104220. PubMed ID: 33096321
[TBL] [Abstract][Full Text] [Related]
20. The Next Frontier of Regulatory T Cells: Promising Immunotherapy for Autoimmune Diseases and Organ Transplantations.
Terry LV; Oo YH
Front Immunol; 2020; 11():565518. PubMed ID: 33072105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
